[Federal Register Volume 66, Number 239 (Wednesday, December 12, 2001)]
[Proposed Rules]
[Pages 64173-64174]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-30731]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

21 CFR PART 1310

[DEA-203C]
RIN 1117-AA52


Establishment of a Threshold for Gamma-Butyrolactone; Correction

AGENCY: Drug Enforcement Administration (DEA), Justice.

ACTION: Notice of proposed rulemaking; correction.

-----------------------------------------------------------------------

SUMMARY: This document corrects the proposed rule ``Establishment of a 
Threshold for Gamma-Butyrolactone'' (DEA-203P) which DEA published in 
the Federal Register on October 24, 2001 (66 FR 53746). The proposed 
rule concerned the establishment of a threshold for the List I chemical 
gamma-butyrolactone (GBL).

For Further Information Contact: Frank L. Sapienza, Chief, Drug and 
Chemical Evaluation Section, Office of Diversion Control, Drug 
Enforcement Administration, Washington, DC 20537, Telephone (202) 307-
7183

Supplementary Information:   

Background

    On Wednesday, October 24, 2001, DEA published a Notice of Proposed 
Rulemaking titled ``Establishment of a Threshold for Gamma-
Butyrolactone'' in the Federal Register (66 FR 53746). The proposed 
regulations that are subject to this correction suggest adding new 
paragraphs at Title 21, Code of Federal Regulations (CFR), 
1310.04(g)(1) and 21 CFR 1310.08. These paragraphs suggest that no 
threshold be established for GBL and that certain transactions in GBL 
be excluded from the definition of a regulated transaction, 
respectively. However, a previous Final Rule, published on Wednesday 
October 17, 2001, already added paragraphs at 21 CFR 1310.04(g)(1)(ii)-
(iv) and 21 CFR 1310.08(j). Therefore, to alleviate any confusion which 
might arise by publication of this proposed rule, DEA is redesignating 
the text of the paragraphs in the proposed rule to align with the 
currently amended Code of Federal Regulations. No substantive changes 
to the proposed text are occurring in this correction. In addition, one 
typographical error is being corrected.
    Accordingly, the publication on October 24, 2001 of the proposed 
rule (DEA-203P), which was the subject of FR Doc. 01-26741, is 
corrected as follows:

[[Page 64174]]

    1. On page 53748, in the first column, sixth line of the fourth 
full paragraph correct ``(ii)'' to read ``(iii)''.

PART 1310--[CORRECTED]

    2. On page 53749, amendatory instruction 2 is corrected to read as 
follows: ``2. Section 1310.04 is proposed to be amended by adding a new 
paragraph (g)(1)(v) to read as follows:''
    3. Corrected Sec. 1310.04(g)(1)(v) reads as follows:


Sec. 1310.04  Maintenance of records.

* * * * *
    (g) * * *
    (1) * * *
    (v) gamma-Butyrolactone (Other names include: GBL; Dihydro-2(3H)-
furanone; 1,2-Butanolide; 1,4-Butanolide; 4-Hydroxybutanoic acid 
lactone; gamma-Hydroxybutyric acid lactone)
* * * * *
    4. On page 53749, amendatory instruction 3 is corrected to read as 
follows: ``3. Section 1310.08 is proposed to be amended by adding a new 
paragraph (k) to read as follows:''
    5. Corrected Sec. 1310.08(k) reads as follows:


Sec. 1310.08  Excluded transactions.

* * * * *
    (k) Domestic, import, and export distributions of gamma-
butyrolactone weighing 16,000 kilograms (net weight) or more in a 
single container.

    Dated: December 5, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control.
[FR Doc. 01-30731 Filed 12-11-01; 8:45 am]
BILLING CODE 4410-09-P